News & Press Releases
Filter by:
Member Joanne Hawana was quoted in a Reuters article about the FDA’s plans to restrict GLP-1 ingredients in non-approved compound drugs. The article reports on the agency’s potential enforcement actions involving Hims & Hers and broader regulatory scrutiny of compounded weight-loss medications.
Big Law Ramps Up Hiring in Trade Practices Amid High Demand
February 4, 2026
The National Law Journal highlighted the addition of Robert Vlasis to Mintz. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.
Legal Risks Complicate Drugmakers' TrumpRx Participation
February 3, 2026
Member Theresa Carnegie shared insights in a Law360 Healthcare Authority article about a federal government bulletin stating that drug manufacturers will be able to sell medications directly to patients through TrumpRx, without violating federal anti-kickback laws. The article sheds light on the potential legal risks associated with excluding telehealth providers, pharmacies, and other parties not covered by the bulletin.
Mintz Adds Winston & Strawn ITC Practice Co-leader in DC
February 2, 2026
Law360 highlighted the addition of Robert Vlasis to Mintz. The article noted Robert’s deep experience handling 337 Section investigations. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.
FERC in 2026: Rising Costs Cloud Regulators’ Options on Data Centers, Transmission and More
January 29, 2026
Utility Dive featured insights from Digital Infrastructure Co-chair Steven Shparber in an article focused on what to expect from FERC in 2026, including the agency’s focus on ensuring recent interconnection and transmission changes are successfully implemented.
Member Theresa Carnegie, Associate Hassan Shaikh, and Law Clerk Grace Callander wrote an article published by the Employee Benefit Plan Review focused on the key provisions of a set of new regulations for PBMs and health plans operating in California, including requirements related to governance and oversight, transparency and pricing, and enforcement.
